Cargando…
Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy
BACKGROUND: Post-infectious glomerulonephritis (PIGN) is an immune complex-mediated glomerular injury that typically resolves. Dominant C3 deposition is characteristic of PIGN, but with the emergence of C3 glomerulonephritis (C3GN) as a distinct entity, it is unclear how the pathologic similarities...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886922/ https://www.ncbi.nlm.nih.gov/pubmed/27274823 http://dx.doi.org/10.1093/ckj/sfw032 |
_version_ | 1782434667963613184 |
---|---|
author | Khalighi, Mazdak A. Wang, Shihtien Henriksen, Kammi J. Bock, Margret Keswani, Mahima Meehan, Shane M. Chang, Anthony |
author_facet | Khalighi, Mazdak A. Wang, Shihtien Henriksen, Kammi J. Bock, Margret Keswani, Mahima Meehan, Shane M. Chang, Anthony |
author_sort | Khalighi, Mazdak A. |
collection | PubMed |
description | BACKGROUND: Post-infectious glomerulonephritis (PIGN) is an immune complex-mediated glomerular injury that typically resolves. Dominant C3 deposition is characteristic of PIGN, but with the emergence of C3 glomerulonephritis (C3GN) as a distinct entity, it is unclear how the pathologic similarities between PIGN and C3GN should be reconciled. Therefore, nephrologists and nephropathologists need additional guidance at the time of biopsy. METHODS: We studied 23 pediatric and young adult patients diagnosed with PIGN. Patients were divided into two groups, one with co-dominance between C3 and immunoglobulins and the other meeting proposed diagnostic criteria for C3GN. Clinical and pathological features were compared. RESULTS: No clinical and/or pathological features could distinguish between those with C3-co-dominant deposits and those with C3 dominance. Nearly all patients in both groups regained their baseline renal function without clinical intervention. CONCLUSIONS: Although the identification of abnormalities of the alternative pathway of complement is characteristic of C3GN, testing is not widely available and the turnaround time often exceeds 1 month. Our study found that PIGN with either co-dominant or dominant C3 deposition in a cohort of young patients has excellent short-term outcomes. Close clinical observation for persistent abnormalities, such as hypocomplementemia, prolonged hematuria or proteinuria, is recommended to single out patients that may harbor intrinsic complement abnormalities. |
format | Online Article Text |
id | pubmed-4886922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48869222016-06-03 Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy Khalighi, Mazdak A. Wang, Shihtien Henriksen, Kammi J. Bock, Margret Keswani, Mahima Meehan, Shane M. Chang, Anthony Clin Kidney J Glomerulonephritis BACKGROUND: Post-infectious glomerulonephritis (PIGN) is an immune complex-mediated glomerular injury that typically resolves. Dominant C3 deposition is characteristic of PIGN, but with the emergence of C3 glomerulonephritis (C3GN) as a distinct entity, it is unclear how the pathologic similarities between PIGN and C3GN should be reconciled. Therefore, nephrologists and nephropathologists need additional guidance at the time of biopsy. METHODS: We studied 23 pediatric and young adult patients diagnosed with PIGN. Patients were divided into two groups, one with co-dominance between C3 and immunoglobulins and the other meeting proposed diagnostic criteria for C3GN. Clinical and pathological features were compared. RESULTS: No clinical and/or pathological features could distinguish between those with C3-co-dominant deposits and those with C3 dominance. Nearly all patients in both groups regained their baseline renal function without clinical intervention. CONCLUSIONS: Although the identification of abnormalities of the alternative pathway of complement is characteristic of C3GN, testing is not widely available and the turnaround time often exceeds 1 month. Our study found that PIGN with either co-dominant or dominant C3 deposition in a cohort of young patients has excellent short-term outcomes. Close clinical observation for persistent abnormalities, such as hypocomplementemia, prolonged hematuria or proteinuria, is recommended to single out patients that may harbor intrinsic complement abnormalities. Oxford University Press 2016-06 2016-05-17 /pmc/articles/PMC4886922/ /pubmed/27274823 http://dx.doi.org/10.1093/ckj/sfw032 Text en © The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Glomerulonephritis Khalighi, Mazdak A. Wang, Shihtien Henriksen, Kammi J. Bock, Margret Keswani, Mahima Meehan, Shane M. Chang, Anthony Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy |
title | Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy |
title_full | Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy |
title_fullStr | Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy |
title_full_unstemmed | Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy |
title_short | Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy |
title_sort | revisiting post-infectious glomerulonephritis in the emerging era of c3 glomerulopathy |
topic | Glomerulonephritis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886922/ https://www.ncbi.nlm.nih.gov/pubmed/27274823 http://dx.doi.org/10.1093/ckj/sfw032 |
work_keys_str_mv | AT khalighimazdaka revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy AT wangshihtien revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy AT henriksenkammij revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy AT bockmargret revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy AT keswanimahima revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy AT meehanshanem revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy AT changanthony revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy |